Baillie Gifford Worldwide Health Innovation Fund B EUR Acc
IE00BGGJJB67
Baillie Gifford Worldwide Health Innovation Fund B EUR Acc/ IE00BGGJJB67 /
Стоимость чистых активов31.05.2024 |
Изменение-0.0202 |
Тип доходности |
Инвестиционная направленность |
Инвестиционная компания |
10.5142EUR |
-0.19% |
reinvestment |
Equity
Worldwide
|
Baillie Gifford IM ▶ |
Инвестиционная стратегия
The Fund aims to provide capital growth over the long term by investing primarily in a global equity portfolio from companies engaged in the healthcare industry and that promotes better healthcare outcomes by driving real change for patients and the healthcare system and evidence care about patients. The Fund will invest at least 90% in shares of companies in global equities in the healthcare industry which are innovative in their focus on areas such as diagnostics, treatment and prevention and contribute to solving a problem for the healthcare system in a method that cares about patients.
Companies are assessed qualitatively on the solution the company is providing to an existing healthcare issue, its ability to democratise access to healthcare solutions and its engagement with its patients. The Fund will comply with the Investment Managers policy on assessing breaches of the United Nations Global Compact Principles for Business. The Fund will be concentrated by the number of stocks held but diversified across a range of healthcare themes. The Fund is actively managed and no index is used for the purposes of determining or constraining the composition of the Fund's portfolio. The Fund's performance (after deduction of costs) is measured against the MSCI ACWI Index. The Fund seeks to materially outperform the index. The return of the Fund is dependent on the performance of the underlying assets.
Инвестиционная цель
The Fund aims to provide capital growth over the long term by investing primarily in a global equity portfolio from companies engaged in the healthcare industry and that promotes better healthcare outcomes by driving real change for patients and the healthcare system and evidence care about patients. The Fund will invest at least 90% in shares of companies in global equities in the healthcare industry which are innovative in their focus on areas such as diagnostics, treatment and prevention and contribute to solving a problem for the healthcare system in a method that cares about patients.
Основные данные
Тип доходности: |
reinvestment |
Категории фондов: |
Equity |
Регион: |
Worldwide |
Branch: |
Sector Health / Pharma |
Бенчмарк: |
MSCI AC World Index |
Начало рабочего (бизнес) года: |
01.10 |
Last Distribution: |
- |
Депозитарный банк: |
Brown Brothers Harriman Trust Ser(IE)Lim |
Место жительства фонда: |
Ireland |
Разрешение на распространение: |
Austria, Germany, Switzerland |
Управляющий фондом: |
Julia Angeles, Marina Record,Rose Nguyen |
Объем фонда: |
104.29 млн
EUR
|
Дата запуска: |
01.10.2018 |
Инвестиционная направленность: |
- |
Условия
Эмиссионная надбавка: |
0.00% |
Max. Administration Fee: |
0.50% |
Минимальное вложение: |
1,000,000.00 EUR |
Deposit fees: |
0.50% |
Комиссионные, взимаемые фондами взаимных инвестиций при погашении акций: |
0.00% |
Упрощенный проспект: |
Скачать (Версия для печати) |
Инвестиционная компания
Товарищества на вере: |
Baillie Gifford IM |
Адрес: |
4/5 School House Lane East, D02 N279, Dublin |
Страна: |
Ireland |
Интернет: |
www.bailliegifford.com
|
Активы
Stocks |
|
99.38% |
Cash |
|
0.61% |
Другие |
|
0.01% |
Страны
United States of America |
|
64.13% |
Denmark |
|
18.42% |
Germany |
|
6.33% |
Netherlands |
|
5.84% |
Japan |
|
1.99% |
China |
|
1.26% |
United Kingdom |
|
0.90% |
Cash |
|
0.61% |
Cayman Islands |
|
0.51% |
Другие |
|
0.01% |
Отрасли
Pharma/Biotechnology |
|
47.29% |
Healthcare appliances |
|
33.60% |
Gesundheitswesen/ Informationstechnologie |
|
10.09% |
Healthcare services |
|
8.40% |
Cash |
|
0.61% |
Другие |
|
0.01% |